HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that data from the ARC-20 study will be presented in a rapid oral session at the 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium taking place February 13 – 15, 2025, in San Francisco, CA. The oral presentation will highligh
More in Trade Show
Trade Show
Riassunto: 24.000 partecipanti registrati affollano i padiglioni della riuscita SPIE Photonics West 2025
BELLINGHAM, Washington–(BUSINESS WIRE)–SPIE, la società internazionale per l’ottica e la fotonica, ha registrato ...
Trade Show
Resumen: 24 000 asistentes se inscribieron y llenaron las salas del exitoso SPIE Photonics West 2025
BELLINGHAM, Washington–(BUSINESS WIRE)–SPIE, la Sociedad Iternacional de Óptica y Fotónica, contó con 24 ...
Trade Show
Howmet Aerospace to Present at Barclays 2025 Industrial Select Conference
PITTSBURGH–(BUSINESS WIRE)–Howmet Aerospace to Present at Barclays 2025 Industrial Select Conference
